One-Stop In Vitro Diagnostics (IVD) CDMO Partner | From Lab to Market
Expert Call: (86) 23-86916205

IVD R&D Services

We deliver full-spectrum customized R&D & assay development CDMO solutions for IVD manufacturers, covering raw material development, assay formulation optimization, method validation, pre-clinical verification & process scale-up across CLIA, ELISA, POCT Lateral Flow, Molecular PCR & Multiplex IVD platforms. From early feasibility study to registered clinical trial sample manufacturing, our expert R&D team supports your entire in vitro diagnostic product lifecycle.
Need More Help!

Accelerate Your IVD Product Launch Timeline via Professional CDMO R&D Support

Gain customized R&D roadmap, global regulatory guidance(NMPA/CE-IVD/FDA), expert technical consultation and free preliminary project assessment with our senior IVD scientists.
Provetta-26

Preparing Your IVD R&D Project | Ensure Smooth Project Kick-off

To shorten your project initiation cycle & improve R&D efficiency, submit your core project parameters (target indication, required technical platform, regulatory target market, expected product specification) via our online form in advance for our pre-project technical review.
Accelerate IVD Innovation with End-to-End CDMO R&D Expertise
In Vitro Diagnostics (IVD) demands robust, reproducible analytical workflows to deliver consistent, clinically compliant diagnostic performance. Our full-service CDMO R&D division covers the complete IVD development lifecycle: from target biomaterial screening, antigen/antibody custom development, assay formula construction, analytical performance optimization, interference & stability validation, up to pre-production process transfer for commercial manufacturing.
Build Your Next NGS Molecular Diagnostic Platform with Confidence
Combining GMP-aligned laboratory infrastructure, ISO13485 compliant quality management system and cross-disciplinary IVD scientist team, we streamline your R&D cycle, cut upfront lab investment and minimize technical & regulatory risks across all mainstream IVD technical platforms:

Immunodiagnostic Platforms: CLIA Chemiluminescence, ELISA Enzyme Immunoassay, Fluorescence Immunoassay(FIA), Latex Turbidimetry, Lateral Flow POCT Rapid Test

Molecular Diagnostic Platforms: Real-Time qPCR, Isothermal Amplification, Multiplex Nucleic Acid Detection, Extraction Kit Formulation, Companion Diagnostic Assay Development

Specialized Custom Projects: Calibrator & Quality Control Material R&D, Matrix-based Reference Panel Preparation, In-house Substrate & Biochemical Reagent Custom Synthesis

Our experienced R&D scientists conduct formulation screening, precision performance testing and accelerated stability validation under ISO13485 controlled cleanroom laboratory environments.

What We Do?

An expanded panel of essential, conditionally essential amino acids, and non-essential amino acids provides clinical utility and supports the development of personalized treatments. A formula for a customized amino-acid blend is provided with each report, offering suggested replacement amounts based on test results.

Core R&D Service Categories

Diagnostic Biomaterial Custom R&D(Antigen, Antibody, Enzyme Raw Material)
POCT Lateral Flow & Fluorescence Immunochromatography Assay Development
CLIA Magnetic Particle Chemiluminescence Reagent Formulation & Optimization
ELISA & Turbidimetric Immunoassay Custom Development & Method Validation
Nucleic Acid PCR & Isothermal Amplification Diagnostic Kit R&D
Custom Buffer, Blocking Solution & Lyoprotectant Formulation

Regulatory & Technical Support

ISO13485 QMS System Establishment & Gap Remediation
NMPA Class I/II/III IVD Registration Technical Documentation Compilation
EU CE-IVD/UKCA/FDA 510(k) Global Regulatory Dossier Preparation
Pre-clinical Performance Verification & Clinical Trial Document Guidance
Calibrator/QC Reference Material Characterization & Value Assignment
Lab-to-GMP Production Process Transfer & Scale-up Consultancy

IVD R&D FAQ | Common Questions About Our CDMO Service

We sort frequently asked technical & commercial questions from global IVD clients to clarify core cooperation rules of our CDMO R&D program.
Our technical manager will tailor customized service scope after reviewing your product positioning, target regulatory market and development budget, including split-mode R&D cooperation (partial outsourced) and full turn-key CDMO development.
Flexible cooperation modes available: single-project ad-hoc R&D contract, frame agreement for multi-product pipeline development, no mandatory long-term exclusive cooperation constraints.
Stage-based milestone payment aligned with R&D deliverables; optional co-development royalty-sharing scheme for early-stage startup biotech partners, we support flexible commercial cooperation for companion diagnostic projects with pharmaceutical companies.

Flexible Cooperation Modes for IVD CDMO R&D Projects

Our tailored cooperation frameworks accommodate startup biotech, mid-size diagnostic enterprises and pharma CD projects with diversified resource allocation demands.
Full Turn-key ODM
Full-cycle R&D from project initiation to formal registered formula delivery
Partial Outsourcing
Targeted service covering raw material production or assay performance fine-tuning
Reference Material Customization
Custom fabrication and full property characterization of diagnostic reference materials
Process Transfer Service
Pilot validation and GMP-compliant production scaling of mature assay formulas
Regulatory Documentation Service
Independent standalone drafting of all IVD regulatory application documents
Royalty-sharing Co-development
Joint R&D with revenue split for early-phase diagnostic product pipelines

Empower Global IVD Enterprises via Reliable CDMO R&D Infrastructure

Professional Controlled Laboratory & Quality-centric IVD Development Ecosystem
Over 95% of global clinical diagnostic decisions rely on accurate IVD reagent performance; we position ourselves as your trusted full-cycle CDMO R&D partner to de-risk your diagnostic product development and global market access.
Client-Centric Custom R&D Service
Our R&D team works closely with each client’s technical team to solve formulation bottlenecks, optimize product sensitivity/specificity, and realize customized performance targets for your target clinical application scenarios.
Data-driven Continuous Quality Improvement
Our central QC laboratory implements full-process batch testing for all in-house developed prototypes; we perform systematic stability study & performance re-verification for all finished R&D deliverables following ISO & regulatory standards.

Book On-site CDMO Lab Inspection & Technical Discussion

Welcome global clients to schedule on-site visit of our ISO13485 certified R&D labs, cleanroom pilot production workshop and QC verification center. Our senior R&D director will provide face-to-face technical discussion for your upcoming IVD project.

    How to Kick Off Your IVD CDMO R&D Project | Four-step Standard Cooperation Process

    Standardized Project Onboarding Ensures Efficient & Traceable R&D Execution

    We follow standardized SOP to manage every outsourced IVD R&D project for full transparency of development progress.
    Strict ISO13485 Quality Control
    Full-cycle Project Progress Tracking
    On-time Milestone Delivery Assurance
    Customized Technical After-service
    01.

    Submit Project Brief

    Fill out our inquiry form to submit your product specs, target platform and market requirements.
    02.

    Technical Feasibility Review

    Our senior scientists evaluate your project and arrange a free technical consultation.
    03.

    Confirm Cooperation Agreement

    Finalize SOW, milestones and payment terms before signing formal cooperation contract.
    04.

    Launch R&D & Progress Update

    We start lab development and deliver regular test reports following agreed schedules.
    Your focus is on IVD product commercialization and we’re here to support your whole R&D journey.